Engineered Nanomaterials in Food and Drugs: From Laboratory to Market

This book pans through three major sections of materials and methods used in the engineering of nanomaterials-their applications, ethical issues, and present market share in the field of food and drugs. It presents information on the kind of materials and processes that are used to synthesize nanomaterials.

Santosh K. Misra is an assistant professor at the Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur, India. He received his postdoctoral and research scientist training at the Department of Bioengineering, University of Illinois at Urbana Champaign, Illinois, USA. He earned his PhD from the Indian Institute of Science (IISc), Bangalore, India. His research training involved the fields of nanomedicine, biomaterials, biomedical devices, and personalized medicine approaches. He has more than 85 research publications, multiple filed/granted patents, book chapters, and extramural national and international funding to his credit from various reputed agencies. He has been awarded various international research presentation awards, the best PhD thesis award from IISc, the prestigious Ramalingaswami fellowship by the government of India, and the Prof. T. R. Vishwanathan Young Faculty Fellow award for teaching excellence, to name a few. His current research interests are in the field of biomedical materials and devices.

Nishima Wangoo is an assistant professor at the Department of Applied Sciences (Chemistry), University Institute of Engineering and Technology (UIET), Panjab University, Chandigarh, India. She earned her PhD in the area of nanoscience and nanotechnology from the Institute of Microbial Technology (CSIR-IMTECH), India. She also has significant scientific experience as a researcher at the Northwestern University, Illinois, USA, and as a postdoctoral researcher at the Nanyang Technological University, Singapore. She has also worked as a project scientist at a DBT Institute in Mohali and was selected for DST INPSIRE Faculty position at the Centre for Nanoscience and Nanotechnology. Her research group deals with the application of nanomaterials in the multidisciplinary area of biosensing, drug delivery, and theranostics. She has 70 international publications and several book chapters to her credit. She has completed 10 extramural research projects and 3 are ongoing. She is a fellow of the Indian National Young Academy of Sciences (INYAS-INSA) and is an active member in its outreach activities. She was selected as the top 50 women in STEM in India in 2022 by the principal scientific advisor to the Government of India and Red Dot Foundation. She was also listed in Women in STEM: Vanguards of India@75 by the Confederation of Indian Industry.

Sangeeta Khare is a principal investigator/research microbiologist at the National Center for Toxicological Research/US Food and Drug Administration (US-FDA) and leads an active team working on host-pathogen/host-microbiome interaction. She earned her PhD in the area of infectious diseases from the All India Institute of Medical Sciences, New Delhi, India. She studied infectious agent/gastrointestinal pathogen-host interaction at the University of Saskatchewan, Canada, and the Texas A&M University, College Station, Texas, USA. Dr Khare has extensive experience working in BSL3- and A-BSL3-level laboratories. Her ongoing research at the US-FDA is on (i) risk assessment of acute and chronic exposure to nanomaterials and xenobiotics on the gastrointestinal tract using animal and non-animal models to assess effects on the commensal microbiota and intestinal barrier and (ii) the use of new advanced technologies, such as NGS, omics, organ on chip, and systems biology approaches to establish decision-tree for the risk assessment for the intestinal toxicity. She has been invited to several research and regulatory agencies to participate in scientific meetings and served as a subject matter expert internationally. She has also received numerous awards and honors for her research at the FDA. The long-term goal of Dr Khare’s research program is to support FDA mission by ＂Evaluating Innovative Emerging Technologies＂ and ＂Modernize Toxicology to Enhance Product Safety.＂ For more details, please visit Sangeeta Khare FDA.